Dr. Charles S. Kuzma
FirstHealth of the Carolinas-Moore Regional Hospital
Expert in Lung Cancer
Expert in Cancer
46 reported clinical trials
105 drugs studied
1 year of experience
About Charles S. Kuzma
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency training in Internal Medicine at FirstHealth of the Carolinas-Moore Regional Hospital.
- Board certified in Internal Medicine by the American Board of Internal Medicine.
- Currently affiliated with FirstHealth of the Carolinas-Moore Regional Hospital as an Internal Medicine physician.
Area of expertise
Charles S. Kuzma has run 18 trials for Lung Cancer. Some of their research focus areas include:
1Lung CancerGlobal Leader
Charles S. Kuzma has run 18 trials for Cancer. Some of their research focus areas include:
FirstHealth Of The Carolinas-Moore Regional Hospital
FirstHealth Of The Carolinas
Clinical Trials Charles S. Kuzma is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originated outside the lung) neuroendocrine cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). The other aim of this trial is to compare using atezolizumab just at the beginning of treatment versus continuing it beyond the initial treatment. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cisplatin and carboplatin are in a class of medications known as platinum-containing compounds that work by killing, stopping or slowing the growth of cancer cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. Giving atezolizumab in combination with a platinum drug (cisplatin or carboplatin) and etoposide may work better in treating patients with poorly differentiated extrapulmonary neuroendocrine cancer compared to standard therapy with a platinum drug (cisplatin or carboplatin) and etoposide alone.
Recruiting1 award Phase 2 & 310 criteria
More about Charles S. KuzmaClinical Trial Related1 year of experience running clinical trials · Led 46 trials as a Principal Investigator · 29 Active Clinical Trials
Treatments Charles S. Kuzma has experience with
- Biospecimen Collection
Breakdown of trials Charles S. Kuzma has run
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles S. Kuzma specialize in?
Charles S. Kuzma focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage III.
Is Charles S. Kuzma currently recruiting for clinical trials?
Yes, Charles S. Kuzma is currently recruiting for 27 clinical trials in Pinehurst North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Charles S. Kuzma has studied deeply?
Yes, Charles S. Kuzma has studied treatments such as Pembrolizumab, Atezolizumab, Paclitaxel.
What is the best way to schedule an appointment with Charles S. Kuzma?
Apply for one of the trials that Charles S. Kuzma is conducting.
What is the office address of Charles S. Kuzma?
The office of Charles S. Kuzma is located at: FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst, North Carolina 28374 United States. This is the address for their practice at the FirstHealth of the Carolinas-Moore Regional Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.